![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
T Cihlar and MS Chen
Department of Biochemistry and Virology, Gilead Sciences, Foster City, California 94404, USA.
Cidofovir [CDV; (S)-1-(3-hydroxy-2-phosphonomethoxyethyl)cytosine] is an acyclic nucleotide analog with potent and selective in vitro and in vivo activities against a broad spectrum of herpesviruses and other DNA viruses. We studied the mechanism of enzymatic synthesis of CDV diphosphate, the putative antiviral metabolite of CDV. The phosphorylation is two-step process catalyzed by several enzymes. An enzymatic activity phosphorylating CDV to its monophosphate derivative was purified from human liver and identified as pyrimidine nucleoside monophosphate kinase (EC 2.7.4.14.). CDV (Km = 2.10 +/- 0.18 mM and Vmax = 1.10 +/- 0.05 micromol/min/mg) was found to be a substantially weaker substrate for purified enzyme than CMP, UMP, or dCMP. Pyrimidine nucleoside monophosphate kinase was used for preparative enzymatic synthesis of CDV monophosphate. Pyruvate kinase (EC 2.7.1.40), creatine kinase (EC 2.7.3.2), and nucleoside diphosphate kinase (EC 2.7.4.6) were found to catalyze CDV diphosphate synthesis from CDV monophosphate, whereas phosphoglycerate kinase (EC 2.7.2.3) and succinyl-CoA synthetase (EC 6.2.1.4) did not. Based on Vmax/Km (phosphorylation efficiency) values determined with enzymes purified from human sources, the most efficient phosphorylation of CDV monophosphate is catalyzed by pyruvate kinase. After infection of human lung fibroblasts with cytomegalovirus, the intracellular activities of pyrimidine nucleoside monophosphate kinase, pyruvate kinase, creatine kinase, and nucleoside diphosphate kinase increased 2-, 1.3-, 3-, and 5- fold, respectively. The metabolism of [3H]CDV in mock- and cytomegalovirus-infected cells was examined. The intracellular levels of CDV monophosphate and CDV diphosphate increased approximately 20- and 8-fold, respectively, in cytomegalovirus-infected cells, presumably due to the stimulation of CDV uptake and higher activities of phosphorylating enzymes.
This article has been cited by other articles:
|
|
 |
|
  J. A.C. Alexandre, B. Roy, D. Topalis, S. Pochet, C. Perigaud, and D. Deville-Bonne Enantioselectivity of human AMP, dTMP and UMP-CMP kinases Nucleic Acids Res., July 10, 2007; (2007) gkm479v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Andrei, D. B. Gammon, P. Fiten, E. De Clercq, G. Opdenakker, R. Snoeck, and D. H. Evans Cidofovir Resistance in Vaccinia Virus Is Linked to Diminished Virulence in Mice J. Virol., October 1, 2006; 80(19): 9391 - 9401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhu, A. Burnette, D. Dorjsuren, P. E. Roberts, M. Huleihel, R. H. Shoemaker, V. E. Marquez, R. Agbaria, and S. Sei Potent Antiviral Activity of North-Methanocarbathymidine against Kaposi's Sarcoma-Associated Herpesvirus Antimicrob. Agents Chemother., December 1, 2005; 49(12): 4965 - 4973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Magee, K. Y. Hostetler, and D. H. Evans Mechanism of Inhibition of Vaccinia Virus DNA Polymerase by Cidofovir Diphosphate Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3153 - 3162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gilbert and G. Boivin Human Cytomegalovirus Resistance to Antiviral Drugs Antimicrob. Agents Chemother., March 1, 2005; 49(3): 873 - 883. [Full Text] [PDF]
|
|
|
|
 |
|
 L. De Bolle, L. Naesens, and E. De Clercq Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy Clin. Microbiol. Rev., January 1, 2005; 18(1): 217 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. De Clercq Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections Clin. Microbiol. Rev., October 1, 2003; 16(4): 569 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Krishnan, Q. Fu, W. Lam, J.-Y. Liou, G. Dutschman, and Y.-C. Cheng Phosphorylation of Pyrimidine Deoxynucleoside Analog Diphosphates. SELECTIVE PHOSPHORYLATION OF L-NUCLEOSIDE ANALOG DIPHOSPHATES BY 3-PHOSPHOGLYCERATE KINASE J. Biol. Chem., February 8, 2002; 277(7): 5453 - 5459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Liekens, J. Neyts, E. De Clercq, E. Verbeken, D. Ribatti, and M. Presta Inhibition of Fibroblast Growth Factor-2-induced Vascular Tumor Formation by the Acyclic Nucleoside Phosphonate Cidofovir Cancer Res., July 1, 2001; 61(13): 5057 - 5064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. De Clercq Vaccinia Virus Inhibitors as a Paradigm for the Chemotherapy of Poxvirus Infections Clin. Microbiol. Rev., April 1, 2001; 14(2): 382 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Van Rompay, M. Johansson, and A. Karlsson Phosphorylation of Deoxycytidine Analog Monophosphates by UMP-CMP Kinase: Molecular Characterization of the Human Enzyme Mol. Pharmacol., September 1, 1999; 56(3): 562 - 569. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Johnson and J. D. Gangemi Selective Inhibition of Human Papillomavirus-Induced Cell Proliferation by (S)-1-[3-Hydroxy-2-(Phosphonylmethoxy)propyl]cytosine Antimicrob. Agents Chemother., May 1, 1999; 43(5): 1198 - 1205. [Abstract] [Full Text]
|
|
|
|
|
|
T. Cihlar, M. D. Fuller, and J. M. Cherrington Characterization of Drug Resistance-Associated Mutations in the Human Cytomegalovirus DNA Polymerase Gene by Using Recombinant Mutant Viruses Generated from Overlapping DNA Fragments J. Virol., July 1, 1998; 72(7): 5927 - 5936. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
